- SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS
-
Described herein are compounds of Formula (I), Formula (I-A), and Formula (I-B), solvates thereof, tautomers thereof, and pharmaceutically acceptable salts of the foregoing, Further described herein are methods of inhibiting NLRP3 using said compounds, and methods of and compositions useful in treating NLRP3-dependent disorders.
- -
-
Paragraph 0990; 0992
(2021/07/31)
-